Arthritis Research & Therapy

official impact factor 4.36

Drugs in development: bisphosphonates and metalloproteinase inhibitors

Jon B Catterall and Tim E Cawston*

Arthritis Res Ther 2003, 5:12-24 doi:10.1186/ar604

Accesses  

  • Last 30 days: 112 accesses
  • Last 365 days: 1081 accesses
  • All time: 9519 accesses